Advertisement
Advertise on MSK
Musculoskeletal Report
January 04, 2011
MSK Report Video Podcasts

Meeting Highlights

ISEMIR 2009: Video coverage of the Meeting
Miami, March 27, 2009
RWCS 2009: Video coverage of the Symposium
Maui, January 14-17, 2009
ACR 2008: News from the Annual Scientific Meeting
San Francisco, October 24-29, 2008
EULAR 2008: Coverage of the Congress
Paris, June 11-14, 2008
ISEMIR 2008: Video coverage of the Meeting
Chicago, April 10, 2008
AAOS 2008: News from the Annual Meeting
San Francisco, March 5-9, 2008

Affiliations

Arthritis Research
Lupus Research Institute - Letting Science Lead the Way to a Cure
RSS Feeds

Roy M. Fleischmann, MD

Roy M. Fleischmann, MD
Clinical Professor of Medicine
University of Texas Southwestern Medical Center
Dallas, Texas


Roy M. Fleischmann is Clinical Professor of Medicine at the University of Texas Southwestern Medical Center at Dallas, USA. He received his MD from the State University of New York, Downstate Medical Center in 1969, before completing his residency in Internal Medicine at the Mt Sinai Hospital, New York City, USA, and his Fellowship in Rheumatology at the College of Physicians and Surgeons, Columbia University, New York City, USA.


He has served as Chief of the Division of Rheumatology at the St Paul University Hospital, Dallas, Texas, USA since 1978. Dr. Fleischmann has been the Co-Medical Director of Radiant Research in Dallas since 1999.


He is a Diplomate of the American Board of Internal Medicine and is a Fellow of the American College of Rheumatology. He has served on the Finance Committee of the American College of Rheumatology and the Fund raising committee of the Research and Education Foundation (REF) of the American College of Rheumatology. He has previously served on the Board of Directors and the Executive Committee of the North Central Chapter of the Arthritis Foundation. He has been President of the Texas Rheumatism Society and has sat on the Governing Board of the Texas Rheumatism Association.


Dr. Fleischmann has been a consultant for many pharmacological companies in the area of trial design, protocol development and CME development. He is a member of the Inflammation Research Association, the Associates of Clinical Pharmacology, and the Drug Information Association. He has been involved in many clinical trials on treatments for osteoarthritis and rheumatoid arthritis, and has published over 60 peer-reviewed articles and in these areas.